NYSE:BMY   Bristol-Myers Squibb Company
strength in drug names, $ENDP up 20% after EPS $MNK another one that gap up on EPS. Looking for $BMY to top out at the 63 level a short term 5% move. Hope for the best prepare for the worst.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。